The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744.
 
Paul David Harker-Murray
Consulting or Advisory Role - Regeneron
 
Peter D. Cole
No Relationships to Disclose
 
Bradford S. Hoppe
Consulting or Advisory Role - Merck
 
David C. Hodgson
No Relationships to Disclose
 
Auke Beishuizen
No Relationships to Disclose
 
Nathalie Garnier
No Relationships to Disclose
 
Salvatore Buffardi
No Relationships to Disclose
 
Maurizio Mascarin
No Relationships to Disclose
 
Andrej Lissat
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; GE Healthcare; Gilead Sciences; Siemens; United Health Group
 
Alev Akyol
Employment - Bristol-Myers Squibb
 
Russell Crowe
Stock and Other Ownership Interests - Bristol Myers Squibb
 
Ju Li
Employment - Bristol-Myers Squibb
 
Richard A. Drachtman
No Relationships to Disclose
 
Kara M Kelly
Research Funding - Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Thierry Leblanc
Consulting or Advisory Role - Bristol-Myers Squibb
 
Stephen Daw
No Relationships to Disclose